|

Chemo-light Maintenance 2 Clinical Trials

1 actively recruiting trial

Also known as: 6-MP, Asparaginase, Cyclophosphomide, Cytarabine, Daunorubicin +4 more

Pipeline

Phase 2/3: 1

Top Sponsors

  • Institute of Hematology & Blood Diseases Hospital, China1

Indications

  • Childhood Leukemia, Acute Lymphoblastic1
  • B Cell Acute Lymphoblastic Leukemia (B-ALL)1
  • Acute Lymphoblastic Leukemia (ALL)1
  • Cancer1

Other1 trial

Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.